128104-82-5 Usage
General Description
(1-Chloro-3,4-dihydro-2-naphthalenyl)methanol, also known as Naphthol AS-MCL, is a chemical compound with a molecular formula C11H11ClO. It is a colorless or light yellow liquid that is commonly used as a reactive dye intermediate and a raw material for the production of various dyes and pigments. This chemical is also used as a colorant in the textile and paper industries. Additionally, (1-Chloro-3,4-dihydro-2-naphthalenyl)methanol is used in the synthesis of pharmaceuticals and as a research chemical in laboratories. It is important to handle this chemical with caution as it may be harmful if inhaled, ingested, or comes into contact with the skin. Proper safety precautions and protective equipment should be used when working with (1-Chloro-3,4-dihydro-2-naphthalenyl)methanol.
Check Digit Verification of cas no
The CAS Registry Mumber 128104-82-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,1,0 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 128104-82:
(8*1)+(7*2)+(6*8)+(5*1)+(4*0)+(3*4)+(2*8)+(1*2)=105
105 % 10 = 5
So 128104-82-5 is a valid CAS Registry Number.
128104-82-5Relevant articles and documents
Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides
Ellingboe,Alessi,Dolak,Nguyen,Tomer,Guzzo,Bagli,McCaleb
, p. 1176 - 1183 (2007/10/02)
A series of substituted 3H-1,2,3,5-oxathiadiazole-2-oxides (6) was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. The oxathiadiazoles 6 were synthesized by a two-step sequence: treatment of a substituted acetonitrile (4) with hydroxylamine to give the corresponding amidoxime (5) and cyclization with thionyl chloride to yield 6. In terms of potency, the 2-naphthalenylmethyl group (as in compound 3) was found to be the optimal substituent in this series. Compound 3 was approximately 5 times more potent than ciglitazone (1).
